Publications

Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Pisanu, Claudia  [Clear All Filters]
Journal Article
Squassina A, Niola P, Lopez JPablo, Cruceanu C, Pisanu C, Congiu D, Severino G, Ardau R, Chillotti C, Alda M et al..  2020.  MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings.. Eur Neuropsychopharmacol. 34:39-49.
Squassina A, Pisanu C, Congiu D, Caria P, Frau D, Niola P, Melis C, Baggiani G, Lopez JPablo, Cruceanu C et al..  2016.  Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.. Eur Neuropsychopharmacol. 26(7):1241-7.
Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U et al..  2021.  HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders.. Sci Rep. 11(1):17823.
Papadima EMerkouri, Niola P, Melis C, Pisanu C, Congiu D, Cruceanu C, Lopez JPablo, Turecki G, Ardau R, Severino G et al..  2017.  Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.. J Mol Neurosci. 62(3-4):304-308.
Schubert KOliver, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, Akiyama K, Ardau R, Arias B et al..  2021.  Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.. Transl Psychiatry. 11(1):606.